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Dynamics of PTH secretion in hemodialysis patients as deter-
mined by the intact and whole PTH assays.
Background. Renal hyperparathyroidism is assessed by mea-
surement of parathyroid hormone (PTH) levels. The intact PTH
assay (I-PTH) not only reacts with 1-84 PTH but also with
large, truncated fragments of non-1-84 PTH. Because the whole
PTH assay (W-PTH) is specific for 1-84 PTH, non-1-84 PTH
is determined by subtracting W-PTH from I-PTH values. These
large circulating PTH fragments may exert a hypocalcemic
effect by contributing to skeletal resistance to 1-84 PTH.
Methods. The dynamic secretion of both 1-84 PTH and non-
1-84 PTH was evaluated during the induction of hypo- and
hypercalcemia in eight hemodialysis patients.
Results. The basal ionized calcium concentration was 1.23
0.03 mmol/L at which time I-PTH, W-PTH, and non-1-84 PTH
values were 276  78 pg/mL, 164  48 pg/mL, and 102  28
pg/mL, respectively. The induction of hypo- and hypercalcemic
changes resulted in a sigmoidal response for all three PTH
moieties, I-PTH, W-PTH, and non-1-84 PTH. During hypocal-
cemia, maximal values of W-PTH were greater than those of
non-1-84 PTH. But during hypercalcemia, minimal values of
W-PTH and non-1-84 PTH were similar. Neither the set points
nor the basal/maximal ratios for W-PTH, I-PTH, and non-1-84
PTH were different. At the baseline ionized calcium concentra-
tion, the W-PTH (1-84 PTH)/non-1-84 PTH ratio was 1.53 
0.15. Changes in ionized calcium resulted in a sigmoidal rela-
tionship with hypocalcemia, increasing this ratio to a maximum
of 2.01  0.30 and hypercalcemia decreasing this ratio to a
minimum of 1.18  0.15 (P  0.01 vs baseline for both hypo-
and hypercalcemia).
Conclusion. Although acute changes in serum calcium pro-
duce similar secretory responses in 1-84 PTH and non-1-84
PTH, the secretory responses are not proportional for these
PTH moieties. Changes in the serum calcium concentration
modulate the ratio of 1-84 PTH/non-1-84 PTH in a sigmoidal
pattern with hypocalcemia maximizing this ratio. Whether
changes in the 1-84 PTH/non-1-84 PTH ratio specifically modu-
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late the calcemic action and other biologic effects of 1-84 PTH
remain to be determined.
Secondary hyperparathyroidism is commonly ob-
served in dialysis patients. Measurement of parathyroid
hormone (PTH) values is used to assess the severity of
hyperparathyroidism, to decide whether to start PTH
suppressive treatment, and to monitor the effectiveness
of treatment. Until recently, the accepted standard for
the measurement of PTH has been the assay for “intact”
PTH (I-PTH) developed in the late 1980s. But recently,
the I-PTH assay was shown to react not only with 1-84
PTH but also with large, truncated fragments of non-
1-84 PTH [1–4]. In humans, 20% to 60% of PTH mea-
sured with the I-PTH assay corresponds to non-1-84 PTH
[1, 3–5]. In dialysis patients, the percent of non-1-84 PTH
measured in the I-PTH assay is generally greater than
in normals [1–6]. A new assay called whole PTH (W-PTH)
has been shown to be specific for 1-84 PTH [4]. Plasma
concentrations of large, truncated fragments of non-
1-84 PTH can be determined by subtracting the W-PTH
(1-84 PTH) value from that measured with the I-PTH
assay [7, 8].
Results from recent studies have suggested that the
7-84 PTH fragment antagonizes the calcemic action of
1-84 PTH. In parathyroidectomized rats, the infusion
of 7-84 PTH was shown to inhibit the calcemic action of
simultaneously infused 1-84 PTH [7]. These results sug-
gest that large, truncated PTH fragments similar to 7-84
PTH may be an important cause of skeletal resistance
to 1-84 PTH in uremia [7]. Moreover, in a study in hemo-
dialysis patients, the 1-84 PTH/non-1-84 PTH ratio was
less than 1 only in those patients with low bone turnover,
a result that also suggests that large carboxy-terminal
fragments may antagonize the skeletal effects of 1-84
PTH [8]. Finally, it was shown that the 7-84 PTH frag-
ment, like other carboxy-terminal fragments, binds only
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to the carboxyl PTH (C-PTH) receptor and does not
affect the binding of 1-84 PTH to the PTH/parathyroid
hormone related peptide (PTHrP) receptor [9–11]. Thus,
it would appear that the 7-84 PTH fragment may decrease
the calcemic action of 1-84 PTH through its interaction
with the C-PTH receptor.
During hypocalcemia, the proportional increase in
middle and late carboxy terminal fragments is less than
that of 1-84 PTH [12–14]. Conversely, during hypercalce-
mia, the proportional decrease in these carboxy terminal
fragments is less than that of 1-84 PTH [12–14]. In hemo-
dialysis patients, the percent of non-1-84 PTH was shown
to directly correlate with the predialysis serum calcium
concentration [7] with an increase in the serum calcium
concentration associated with a reduction in the ratio
of 1-84 PTH/non-1-84 PTH [8]. While the proportional
secretion of 1-84 PTH and non-1-84 PTH may be modi-
fied by the predialysis serum calcium concentration [7],
there is limited information showing the dynamics of
secretion of non-1-84 PTH during the induction of hypo-
and hypercalcemia in the same hemodialysis patient.
The goals of the present study were (1) to evaluate
the dynamic secretion of both 1-84 PTH and non-1-84
PTH in the same hemodialysis patient during the induc-
tion of hypo- and hypercalcemia; (2) to assess the acute
regulation and proportional secretion of PTH fragments;
and (3) to compare the 1-84 PTH-calcium curve with
the I-PTH-calcium and non-1-84 PTH-calcium curves.
METHODS
The criteria for inclusion of chronic hemodialysis pa-
tients were (1) clinically stable with no recent illnesses;
(2) an I-PTH value between 150 and 600 pg/mL; (3) a
normal serum calcium concentration; (4) a serum phos-
phorus concentration less than 6 mg/dL during the 2
months before study; and (5) no calcitriol treatment
during the previous 6 months. Eight patients, four males
and four females, agreed to participate in the study. All
patients had been on hemodialysis for more than 12
months and no patient was diabetic. The protocol was
approved by the Institutional Review Board at the Hos-
pital Universitario Reina Sofia in Cordoba, Spain. The
mean age of the patients was 62.8 years (range, 55 to 69
years). The mean duration of hemodialysis was 98
months (range, 15 to 319 months). The primary phospho-
rus binder was calcium carbonate.
Maximal secretion and suppression of W-PTH and
I-PTH were determined by performing a hemodialysis
with a low (0.75 mmol/L) and high (1.75 mmol/L) calcium
dialysate separated by 1 week [15–18]. In one half of the
patients, dialysis with the high calcium dialysate pre-
ceded that with the low calcium dialysate. Blood was
drawn at regular intervals (basal, 10, 20, 30, 45, 60, 90,
120, 150, 180, and 210 minutes from the beginning of
the hemodialysis session) for measurement of ionized
calcium and W-PTH and I-PTH. From the data obtained
during dialysis-induced hypo- and hypercalcemia, the
following terms were defined for W-PTH, I-PTH, and
non-1-84 PTH: (1) basal PTH was the predialysis PTH
level; (2) maximal PTH was the highest PTH level ob-
served in response to hypocalcemia; the designation of
maximal PTH also required that an additional reduction
of the serum calcium concentration did not further in-
crease the PTH value; (3) minimal PTH was the lowest
PTH level during suppression by hypercalcemia; the des-
ignation of minimal PTH also required that a further
increase in the serum calcium concentration did not re-
sult in any additional decrease in the PTH value; (4) the
ratio of basal to maximal PTH was the basal PTH divided
by the maximal PTH and this fraction was multiplied by
100 to provide a percentage; in normal volunteers, this
ratio is 20 to 25% [19]; by correcting the actual PTH for
the overall capacity to produce PTH (maximal PTH), a
measure of the relative degree of PTH stimulation is
obtained; (5) the set point of calcium was defined as we
have done previously as the serum calcium concentration
at which maximal PTH secretion was reduced by 50%
[15–18]; moreover, as was done in other studies, the set
point of calcium was also calculated by the method of
Brown [20] in which the set point of calcium is the serum
calcium at the midrange between the minimal and maxi-
mal PTH [21, 22]; (6) the basal serum calcium was the
serum calcium concentration at the basal (predialysis)
PTH; (7) the serum calcium at maximal PTH secretion
was the serum calcium level at which maximal PTH se-
cretion was achieved; and (8) the serum calcium at mini-
mal PTH secretion was the serum calcium level at which
minimal PTH secretion was achieved. To assess the cal-
cium-dependent changes in the three PTH moieties, the
plasma PTH concentration and the percent of maximal
PTH stimulation were plotted against the calcium values
extrapolated from the parathyroid function curve of each
patient. Finally, as was done in previous studies [5, 8],
the ratio of W-PTH (1-84 PTH) to non-1-84 PTH was
calculated at baseline and during changes in the ionized
calcium concentration.
Laboratory measurements
During the low and high calcium dialysis studies, ion-
ized calcium was measured with a calcium selective elec-
trode (Bayer Diagnostics, Barcelona, Spain) and mea-
surements were performed immediately after the sample
was obtained. Otherwise, serum calcium as well as phos-
phorus, alkaline phosphatase, albumin, and aluminum
were measured using standard laboratory techniques.
PTH was measured using the Duo PTH Kit (Scantibodies
Laboratory, Santee, CA, USA). The kit contains two
immunoradiometric assays. Both assays share a poly-
clonal antibody (anti-PTH 39-84) coated on to the sur-
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Table 1. Dynamics of parathyroid hormone (PTH) secretion during the induction of hypo- and hypercalcemia
Intact PTH Whole PTH Non-1-84 PTH
Basal PTH pg/mL 27678 16448a 10228a,b
Maximal PTH pg/mL 721101 47759a 25347a,b
Minimal PTH pg/mL 11216 588a 529a
Basal/maximal PTH % 377 346 406
Calcium at PTH maximum mmol/L 1.080.03 1.080.03 1.080.04
Calcium at PTH minimum mmol/L 1.350.02 1.360.02 1.330.01
Set point (50%) mmol/L 1.190.03 1.180.03 1.200.03
Set point (midrange) mmol/L 1.170.03 1.170.03 1.170.03
MeanSE.
a P  0.05 as compared with intact PTH; b P  0.05 as compared with whole PTH
face of polystirene beads as a solid-phase. The immuno-
radiometric assay for W-PTH utilizes a tracer antibody
directed against the 1-4 amino terminal region of PTH.
The use of this antibody is designed to be specific for
1-84 PTH [4]. The immunoradiometric assay for I-PTH
uses a specific polyclonal antibody directed against 7-34
PTH. With this antibody both 1-84 PTH and large, trun-
cated fragments of non-1-84 PTH are detected. For the
I-PTH and W-PTH assays, the normal reference ranges
are 14 to 66 pg/mL and 7 to 36 pg/mL, respectively. The
intra- and interassay coefficients of variation were 5%
and7%, respectively, for both assays. The plasma con-
centration of non-1-84 PTH was determined by sub-
tracting the 1-84 PTH (whole) assay value from the
I-PTH assay value.
Statistics
Results are expressed as mean SE. When data were
normally distributed as assessed by the Shapiro-Wilks
test, means were compared using paired t test or general
linear model for repeated measures followed by the
Bonferroni post hoc test. The Friedman and Wilcoxon
tests were used when data were not normally distributed.
Differences were considered significant when the P value
was less than 0.05.
RESULTS
At entry, the serum calcium and phosphorus values
were 9.9  0.3 mg/dL and 4.6  0.9 mg/dL, respectively.
All patients had serum aluminum levels below 35 g/L,
with a mean value of 15  7 g/L. Serum albumin and
alkaline phosphatase concentrations were 3.6 0.4 g/dL
and 217  69 IU/L, respectively.
The basal ionized calcium concentration was 1.23 
0.03 mmol/L at which I-PTH, W-PTH, and non-1-84 PTH
values were 276 78 pg/mL, 164 48 pg/mL, and 102
28 pg/mL, respectively (Table 1). At baseline, W-PTH
was 60%  3% of the I-PTH value while non-1-84 PTH
was 40%  6% of I-PTH. Hemodialysis with a low and
high calcium dialysate resulted in sigmoidal PTH-cal-
Fig. 1. Changes in the secretion of intact parathyroid hormone
(I-PTH), whole PTH (W-PTH), and non-1-84 PTH are shown in rela-
tion to the ionized calcium concentration. Horizontal lines at the top
of the figure indicate the range of ionized calcium concentration at
which differences were significant.
cium curves for all three PTH moieties (Fig. 1). Hypocal-
cemia increased I-PTH, W-PTH, and non-1-84 PTH val-
ues and the three PTH assay values reached maximal
levels at an ionized calcium concentration of 1.08  0.03
mmol/L. As would be expected, maximal values of
I-PTH were greater than W-PTH values. The latter were
also greater than the non-1-84 PTH value. Hypercalce-
mia decreased values of I-PTH, W-PTH, and non-1-84
PTH. Maximal inhibition of the three assay values
was achieved at similar ionized calcium concentrations:
1.35  0.02 mmol/L (I-PTH), 1.36  0.02 mmol/L
(W-PTH), and 1.33  0.01 mmol/L (non-1-84 PTH). At
minimal PTH, the concentrations of W-PTH and non-
1-84 PTH were similar (Table 1) (Fig. 1). The W-PTH
concentration was greater than that of non-1-84 PTH
from ionized calcium values of 0.95 to 1.20 mmol/L. In
the hypercalcemic range, no differences were observed
between W-PTH and non-1-84 PTH values.
The relationship between the ionized calcium concen-
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Fig. 2. Changes in the secretion of intact parathyroid hormone
(I-PTH), whole PTH (W-PTH), and non-1-84 PTH (expressed as the
percent of maximal) are shown in relation to the ionized calcium concen-
tration. Horizontal lines at the top of the figure indicate the range of
ionized calcium concentration at which differences were significant.
tration and the percent of maximal PTH stimulation for
I-PTH, W-PTH, and non-1-84 PTH is shown in Figure
2. With ionized calcium concentrations ranging from 0.95
to 1.25 mmol/L, values of the three PTH moieties as a
percent of maximal stimulation were similar indicating
that during hypocalcemia, the degree of stimulation for
W-PTH and I-PTH was not different. During PTH sup-
pression between ionized calcium values from 1.30 to
1.50 mmol/L, non-1-84 PTH as a percent of its maximal
value was greater than that of both W-PTH and I-PTH.
The set points for the three PTH moieties were not
different (Table 1). Also the basal/maximal ratios for
W-PTH, I-PTH, and non-1-84 PTH were not different
(Table 1).
In Figure 3, the W-PTH/non-1-84 PTH ratio is plotted
against the ionized calcium concentration. At baseline
ionized calcium concentration, the W-PTH/non-1-84 PTH
ratio was 1.53 0.15 (range, 1.03 to 1.65). Hypercalcemia
resulted in a progressive decrease in the W-PTH/non-
1-84 PTH ratio (minimum value less than baseline, 1.18
0.15 vs. 1.53  0.15, P  0.01). Hypocalcemia produced
a progressive increase in the W-PTH/non-1-84 PTH ratio
(maximum value greater than baseline, 2.01  0.30 vs.
1.53  0.15, P  0.01). The minimum W-PTH/non-1-84
PTH ratio was observed at an ionized calcium of 1.38 
0.03 mmol/L, a value not different from the ionized cal-
cium concentration required to produce minimum levels of
the three PTH moieties. However, the maximum W-PTH/
non-1-84 PTH ratio was observed at an ionized calcium
of 1.14  0.03 mmol/L, a value significantly greater than
the ionized calcium concentration needed to produce
maximum levels of the three PTH moieties.
Fig. 3. Changes in the whole parathyroid hormone (W-PTH)/ non-
1-84 PTH ratio are shown in relation to the ionized calcium concentra-
tion. *P 0.05 as compared with the mean value at 1.25 mmol/L ionized
calcium concentration.
Fig. 4. Changes in whole parathyroid hormone (W-PTH), expressed
as percent of intact PTH (I-PTH), are shown in relation to the ionized
calcium concentration. *P  0.05 as compared with the mean value at
1.25 mmol/L ionized calcium concentration.
From the basal serum calcium concentration of 1.23
mmol/L, the concentration of W-PTH relative to I-PTH
progressively increased during hypocalcemia and de-
creased during hypercalcemia (Fig. 4). At an ionized
calcium of 1.40 mmol/L, W-PTH as percent of I-PTH
was 53.6%  1.7% but this ratio was 66%  2.2% at
an ionized calcium of 1.0 mmol/L (P  0.001). Between
0.95 and 1.0 mmol/L there was no change in the W-PTH/
I-PTH ratio.
DISCUSSION
The present study was designed to evaluate calcium-
induced changes in I-PTH, W-PTH, and non-1-84 PTH in
hemodialysis patients. Our results show that the dynamic
secretion of the three PTH moieties have several inter-
esting similarities. All three PTH moieties were stimu-
lated by hypocalcemia and suppressed by hypercalcemia
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and each of the PTH moieties was best expressed as a
sigmoidal curve. As a percent of maximal PTH induced
by hypocalcemia, the values during the induction of hy-
pocalcemia were remarkably similar (Fig. 2).
Patients included in the present study were not on
calcitriol treatment and had mild to moderate elevations
in PTH levels. Thus, we were not able to compare our
results to those in hemodialysis patients with severe hy-
perparathyroidism. But, results available from a limited
number of studies do suggest the possibility of differ-
ences [1, 23]. In one study, hemodialysis patients were
separated into mild and severe hyperparathyroidism
based on the bone histology [23]. Others have used 1-84
PTH values to separate patients [1, 24]. Both groups of
investigators reported that the ratio of C-PTH/1-84 PTH
was greater in hemodialysis patients with mild than in
those with severe hyperparathyroidism.
In our patients, the mean ratio of W-PTH/non-1-84
PTH at baseline was 1.53 0.15 and none of the patients
had a ratio 1 even though in some patients, the 1-84
PTH (W-PTH) value was only minimally elevated. Mo-
nier-Faugere et al [8] have reported that all their patients
with low bone turnover had a W-PTH/non-1-84 PTH
ratio1. But, Coen et al [5] did not find any difference in
the W-PTH/non-1-84 PTH ratio among dialysis patients
with low turnover osteodystrophy, hyperparathyroid
bone disease, and mixed osteodystrophy. Also, Reichel
et al [25] have reported that in 141 hemodialysis patients,
the ratio of 1-84 PTH to non-1-84 PTH was 1 in only
eight patients. Similarly, Salusky et al [26] did not report
any difference in the W-PTH/non-1-84 PTH ratio in dial-
ysis patients with different types of bone histology. Thus,
whether the W-PTH/non-1-84 PTH ratio is of value in
detecting low bone turnover in dialysis patients would
seem to be disputed.
Regarding the determination of non-1-84 PTH by the
subtraction of W-PTH from I-PTH values, preliminary
results from a recent study have suggested a potentially
complicating issue [abstract; D’Amour et al, J Bone
Miner Res 17 (Suppl 1):S391, 2002]. In that study, it
was shown by high-performance liquid chromatography
(HPLC) that besides 1-84 PTH, the W-PTH assay recog-
nized a pre 1-84 PTH peak that was not recognized by
the I-PTH assay. In dialysis patients, this peak accounted
for 22% 7% of PTH measured with the W-PTH assay.
In the basal state of our patients, such a 22% reduction
of the W-PTH determination of 1-84 would mean that
non-1-84 PTH would increase by 35 pg/mL. Moreover,
if these preliminary results are confirmed, studies would
need to be performed to determine whether the induc-
tion of hypo- and hypercalcemia would disproportion-
ately affect the amount of pre-1-84 PTH recognized by
the W-PTH assay.
The relationship between ionized calcium and the
W-PTH/non-1-84 PTH ratio was a sigmoidal curve with
a maximum and minimum suggesting a coordinated reg-
ulation in the secretion of 1-84 PTH and non-1-84 PTH.
If the calcemic action of PTH is affected by this ratio,
it would seem that a greater ratio would be expected
with hypocalcemia than with hypercalcemia. It is also of
interest that the maximum W-PTH/non-1-84 PTH ratio
was achieved with a serum calcium concentration of
1.14  0.03 mmol/L, which was higher than the ionized
serum calcium concentration needed to achieve maxi-
mum levels of W-PTH and non-1-84 PTH (1.08  0.03
mmol/L). According to previous reports, the calcemic
action of the W-PTH may not depend solely on its abso-
lute concentration but also on its concentration relative
to that of non-1-84 PTH [7–9, 12]. Thus, even before
maximal W-PTH values were achieved, a maximal
W-PTH/non-1-84 PTH ratio at a higher ionized calcium
concentration might possibly have the potential to opti-
mize the calcemic effect of PTH.
Parameters of the PTH calcium curves for the three
PTH moieties were determined and no differences were
found in the basal/maximal PTH ratio, ionized calcium
concentrations at maximal and minimal PTH, and set
point. At every ionized calcium concentration from 1 to
1.30 mmol/L, the correlation coefficient (r value) for the
comparison between W-PTH and I-PTH was 0.95 or
greater and the P value was 0.001 (data not shown).
At ionized calcium concentrations of 1.35 and 1.40
mmol/L, the r values were 0.91 and 0.92, respectively.
Thus, it would appear that in previous studies in which
only the I-PTH assay was used, conclusions on PTH
secretion based on the I-PTH assay do accurately reflect
secretion of 1-84 PTH during hypocalcemic stimulation
and hypercalcemic suppression of PTH secretion.
It was first suggested approximately 3 years ago that
7-84 PTH interfered with the calcemic action of 1-84
PTH by competing for PTH receptor binding [7]. But
more recent reports have shown that the 7-84 PTH frag-
ment does not directly interfere with the binding of 1-84
PTH to the PTH/PTHrP receptor, but rather acts at the
C-PTH receptor in an unspecified manner to interfere
with the calcemic action of 1-84 PTH [9–11]. Moreover, it
was shown that smaller carboxy-terminal PTH fragments
may also interfere with the calcemic and phosphaturic
actions of 1-84 PTH [9].
Recently D’Amour has stated that during normal con-
ditions, 1-84 PTH composes only 20% of total secreted
PTH with the remainder being composed of a number
of different carboxy-terminal PTH fragments [24]. More-
over, of the total carboxy-terminal PTH fragments, per-
haps only 10% of these are the large non-1-84 PTH
fragment recognized by the I-PTH assay. During hypo-
calcemia, all forms of PTH are markedly stimulated with
1-84 PTH increasing to 30% and carboxy-terminal PTH
fragments decreasing to 70% of total secreted PTH. Con-
versely, during hypercalcemia, all forms of PTH are sup-
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pressed but carboxy-terminal PTH fragments increase
to 90% of total secreted PTH and 1-84 PTH only ac-
counts for 10% [24]. Both the large non-1-84 PTH frag-
ments recognized by the I-PTH assay and the smaller
carboxy-terminal fragments not recognized by the I-PTH
assay bind to the C-PTH receptor [8]. But, whether the
former has a specific effect that is different from the
latter requires further study. Another important area
needing study is whether the hyperplastic parathyroid
gland due to renal failure secretes the same spectrum of
PTH moieties and in the same proportion as the normal
parathyroid gland during hypo- and hypercalcemia and
at normal calcium values. But, even if the secretory ratios
of the different PTH moieties are not affected by renal
hyperparathyroidism, another factor that would affect
these ratios is their metabolism. In renal failure, the
metabolism of carboxy-terminal PTH fragments is slower
than that of 1-84 PTH [24, 27, 28] and such a response
would increase the ratio of carboxy-terminal PTH frag-
ments to 1-84 PTH independent of parathyroid gland
secretion. Thus, if indeed the ratio of carboxy-terminal
PTH fragments to 1-84 PTH does play an important role
in the biologic activity of PTH, many questions remain
to be answered, especially in the azotemic patient.
If biologic relevance is affected by the total amount
of carboxy-terminal PTH fragments, then just evaluating
the large non-1-84 PTH fragments recognized by the
I-PTH assay may not provide all the necessary informa-
tion. Perhaps the reason that a low ratio of 1-84 PTH/
non-1-84 PTH was found by some to be helpful for the
diagnosis of low bone turnover [8] is that non-1-84 PTH
measured by the I-PTH assay has a specific effect inde-
pendent of other carboxy-terminal fragments or that it
does reflect the total amount of carboxy-terminal frag-
ments of PTH present. In one study of hemodialysis
patients, it was shown that the ratio of C-PTH (53-84
PTH)/1-84 PTH was greater in dialysis patients with ady-
namic bone than in dialysis patients with severe osteitis
fibrosa [23]. To obtain these results, we used the individ-
ual patient data presented in the paper and calculated
the ratio of carboxy-PTH/1-84 PTH, which was greater
(P  0.05) in patients with adynamic bone than in those
with osteitis fibrosa. The greater proportional increase
in carboxy-PTH in patients with adynamic bone suggests
that carboxy-PTH may have a biologic effect.
CONCLUSION
Although acute changes in the serum calcium concen-
tration produce a similar secretory response of 1-84 PTH
and non-1-84 PTH, the changes in each are not propor-
tional. The ratio of 1-84 PTH/ non-1-84 PTH increases
with hypocalcemia and decreases with hypercalcemia in
a nonlinear and sigmoidal pattern. Thus, the serum cal-
cium concentration seems to modulate the proportional
secretion of 1-84 PTH and non-1-84 PTH by the parathy-
roid glands. Whether changes in the ratio of 1-84 PTH/
non-1-84 PTH or the ratio of 1-84 PTH to the total
amount of carboxy-terminal PTH fragments specifically
modulate the calcemic action and other biologic effects
of 1-84 PTH remain to be determined.
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